Table 2 of Lu, Mol Vis 2012; 18:2255-2264.

Table 2. Expression of CD11c, CD80, CD86, MHC II, and dextran on DCs.

  DCs treatment


Index

immature

LPS
LPS + 25%
supernatant
LPS + 50%
supernatant		 LPS + 50%
supernatant +
TGF-β2 antibody
CD80 18.62±3.66 94.17±6.74 61.44±4.76A 48.75±4.69AB 65.21±4.76C
CD86 48.06±7.60 177.05±12.52 131.94±10.00A 107.22±9.78AB 133.56±8.63C
MHC II 91.92±11.29 253.10±10.43 191.73±19.35A 151.77±13.94AB 184.28±9.29C
dextran ― 347.51±14.42 387.10±10.73A 439.40±21.46AB 390.23±12.67C
CD11c 50.40±3.20 49.79±4.12 51.15±3.80NS 48.49±4.95NS 49.52±4.16NS

Data represent mean value±standard deviation of mean fluorescence intensity (MFI). A, p<0.05 compared with DCs treated with LPS; B, p<0.05 compared with DCs treated with LPS + 25% CSCs culture supernatant; C, p<0.05 compared with DCs treated with LPS + 50% CSCs culture supernatant; NS, no significance.

Lu, Mol Vis 2012; 18:2255-2264. http://www.molvis.org/molvis/v18/a239

©2012 Molecular Vision http://www.molvis.org/molvis/

ISSN 1090-0535